Catherine M. Broome

1.9k total citations · 1 hit paper
66 papers, 1.1k citations indexed

About

Catherine M. Broome is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Catherine M. Broome has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 25 papers in Genetics and 25 papers in Immunology. Recurrent topics in Catherine M. Broome's work include Blood groups and transfusion (41 papers), Erythrocyte Function and Pathophysiology (24 papers) and Platelet Disorders and Treatments (20 papers). Catherine M. Broome is often cited by papers focused on Blood groups and transfusion (41 papers), Erythrocyte Function and Pathophysiology (24 papers) and Platelet Disorders and Treatments (20 papers). Catherine M. Broome collaborates with scholars based in United States, United Kingdom and Italy. Catherine M. Broome's co-authors include Alexander Röth, David J. Kuter, Wilma Barcellini, Marc Michel, Bernd Jilma, Sigbjørn Berentsen, Maha Hussain, John Gutheil, David J. Vaughn and Avi B. Markowitz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Catherine M. Broome

59 papers receiving 1.1k citations

Hit Papers

Diagnosis and treatment o... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
    2019 286 citations Ulrich Jäger, Wilma Barcellini et al. Blood Reviews profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Catherine M. Broome 717 416 250 209 170 66 1.1k
Bouchra Asli 358 0.5× 78 0.2× 206 0.8× 256 1.2× 88 0.5× 30 1.1k
Louis Terriou 807 1.1× 132 0.3× 790 3.2× 567 2.7× 87 0.5× 112 1.8k
J. C. W. Marsh 984 1.4× 76 0.2× 374 1.5× 319 1.5× 116 0.7× 26 1.3k
Zdeněk Adam 522 0.7× 131 0.3× 112 0.4× 100 0.5× 75 0.4× 156 929
Raphaël Szalat 397 0.6× 88 0.2× 90 0.4× 157 0.8× 67 0.4× 64 954
Olga Rios 703 1.0× 58 0.1× 252 1.0× 178 0.9× 55 0.3× 27 892
André Baruchel 757 1.1× 92 0.2× 161 0.6× 195 0.9× 49 0.3× 45 1.7k
Raphael Levey 211 0.3× 142 0.3× 192 0.8× 102 0.5× 175 1.0× 15 913
Aishwarya Ravindran 187 0.3× 438 1.1× 452 1.8× 182 0.9× 73 0.4× 65 1.6k
Valérie Proulle 606 0.8× 55 0.1× 191 0.8× 111 0.5× 83 0.5× 52 1.0k

Countries citing papers authored by Catherine M. Broome

Since Specialization
Citations

This map shows the geographic impact of Catherine M. Broome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine M. Broome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine M. Broome more than expected).

Fields of papers citing papers by Catherine M. Broome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine M. Broome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine M. Broome. The network helps show where Catherine M. Broome may publish in the future.

Co-authorship network of co-authors of Catherine M. Broome

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine M. Broome. A scholar is included among the top collaborators of Catherine M. Broome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine M. Broome. Catherine M. Broome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cooper, Nichola, David J. Kuter, Henrik Frederiksen, et al.. (2024). Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study. Blood. 144(Supplement 1). 3836–3836. 6 indexed citations
3.
Röth, Alexander, Sigbjørn Berentsen, Wilma Barcellini, et al.. (2024). Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B. EClinicalMedicine. 74. 102733–102733. 5 indexed citations
4.
5.
Röth, Alexander, Catherine M. Broome, Wilma Barcellini, et al.. (2024). Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension. EClinicalMedicine. 74. 102732–102732. 1 indexed citations
6.
7.
Röth, Alexander, Catherine M. Broome, Wilma Barcellini, et al.. (2023). Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. Blood Advances. 7(19). 5890–5897. 8 indexed citations
8.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2023). Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. American Journal of Hematology. 98(8). 1246–1253. 16 indexed citations
9.
Broome, Catherine M., Donald M. Arnold, Caroline Piatek, et al.. (2023). PB2554: DESIGN OF A PHASE 1B OPEN-LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN-303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY-4). HemaSphere. 7(S3). e691820b–e691820b. 1 indexed citations
10.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2022). Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results. Haematologica. 107(7). 1698–1702. 21 indexed citations
11.
12.
Ohanian, Maro, José A. Cancelas, Robertson D. Davenport, et al.. (2021). Freeze‐dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies. American Journal of Hematology. 97(3). 256–266. 13 indexed citations
13.
Broome, Catherine M., Alexander Röth, David J. Kuter, et al.. (2020). Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia. Blood. 136(Supplement 1). 14–15. 12 indexed citations
14.
Broome, Catherine M., Megan A. Mullins, Xiaohui Jiang, et al.. (2020). Increased risk of thrombotic events in cold agglutinin disease: A 10‐year retrospective analysis. Research and Practice in Thrombosis and Haemostasis. 4(4). 628–635. 53 indexed citations
15.
16.
Jäger, Ulrich, Wilma Barcellini, Catherine M. Broome, et al.. (2019). Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Reviews. 41. 100648–100648. 286 indexed citations breakdown →
17.
Ahn, Jaeil, et al.. (2017). Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis. Blood. 130. 2331–2331. 1 indexed citations
18.
Broome, Catherine M., et al.. (2017). Acquired Generalized Lipodystrophy Following Immune Thrombocytopenia. The American Journal of Medicine. 130(10). e445–e446. 3 indexed citations
19.
Burris, Howard A., Denise A. Yardley, Suzanne F. Jones, et al.. (2004). Phase II Trial of Trastuzumab Followed by Weekly Paclitaxel/Carboplatin As First-Line Treatment for Patients With Metastatic Breast Cancer. Journal of Clinical Oncology. 22(9). 1621–1629. 87 indexed citations
20.
Broome, Catherine M. & Marie L. Borum. (1998). CANCER AND WOMEN. Medical Clinics of North America. 82(2). 321–333. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bouchra Asli Breakdown of academic impact, for papers by Louis Terriou Breakdown of academic impact, for papers by J. C. W. Marsh Breakdown of academic impact, for papers by Zdeněk Adam Breakdown of academic impact, for papers by Raphaël Szalat Breakdown of academic impact, for papers by Olga Rios Breakdown of academic impact, for papers by André Baruchel Breakdown of academic impact, for papers by Raphael Levey Breakdown of academic impact, for papers by Aishwarya Ravindran Breakdown of academic impact, for papers by Valérie Proulle
Rankless by CCL
2026